Wiench R, Paliga D, Mertas A, Bobela E, Kuska-Kielbratowska A, Bordin-Aykroyd S
Dent J (Basel). 2024; 12(3).
PMID: 38534272
PMC: 10969471.
DOI: 10.3390/dj12030048.
Vetchaporn S, Rangsri W, Ittichaicharoen J, Rungsiyakull P
Int J Dent. 2021; 2021:6814027.
PMID: 34745263
PMC: 8570874.
DOI: 10.1155/2021/6814027.
Yan Y, Cheng N, Jan C, Tsai M, Chiou J, Ou-Yang M
Sensors (Basel). 2021; 21(9).
PMID: 34066507
PMC: 8125388.
DOI: 10.3390/s21093219.
Lingen M, Tampi M, Urquhart O, Abt E, Agrawal N, Chaturvedi A
J Am Dent Assoc. 2017; 148(11):797-813.e52.
PMID: 29080605
PMC: 7366378.
DOI: 10.1016/j.adaj.2017.08.045.
Betz C, Leunig A
HNO. 2017; 51(12):1019-1035.
PMID: 28271253
DOI: 10.1007/s00106-003-0960-5.
Accuracy of autofluorescence in diagnosing oral squamous cell carcinoma and oral potentially malignant disorders: a comparative study with aero-digestive lesions.
Luo X, Xu H, He M, Han Q, Wang H, Sun C
Sci Rep. 2016; 6:29943.
PMID: 27416981
PMC: 4945954.
DOI: 10.1038/srep29943.
Autofluorescence based diagnostic techniques for oral cancer.
Balasubramaniam A, Sriraman R, Sindhuja P, Mohideen K, Parameswar R, Haris K
J Pharm Bioallied Sci. 2015; 7(Suppl 2):S374-7.
PMID: 26538880
PMC: 4606622.
DOI: 10.4103/0975-7406.163456.
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.
Macey R, Walsh T, Brocklehurst P, Kerr A, Liu J, Lingen M
Cochrane Database Syst Rev. 2015; (5):CD010276.
PMID: 26021841
PMC: 7087440.
DOI: 10.1002/14651858.CD010276.pub2.
Evaluation of a low-cost, portable imaging system for early detection of oral cancer.
Rahman M, Ingole N, Roblyer D, Stepanek V, Richards-Kortum R, Gillenwater A
Head Neck Oncol. 2010; 2:10.
PMID: 20409347
PMC: 2867772.
DOI: 10.1186/1758-3284-2-10.
Autofluorescence-guided surveillance for oral cancer.
Jayaprakash V, Sullivan M, Merzianu M, Rigual N, Loree T, Popat S
Cancer Prev Res (Phila). 2009; 2(11):966-74.
PMID: 19892665
PMC: 3653312.
DOI: 10.1158/1940-6207.CAPR-09-0062.
Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia.
Nitin N, Rosbach K, El-Naggar A, Williams M, Gillenwater A, Richards-Kortum R
Neoplasia. 2009; 11(6):542-51.
PMID: 19484143
PMC: 2685443.
DOI: 10.1593/neo.09188.
Diagnostic aids in the screening of oral cancer.
Fedele S
Head Neck Oncol. 2009; 1:5.
PMID: 19284694
PMC: 2654034.
DOI: 10.1186/1758-3284-1-5.
Multispectral optical imaging device for in vivo detection of oral neoplasia.
Roblyer D, Richards-Kortum R, Sokolov K, El-Naggar A, Williams M, Kurachi C
J Biomed Opt. 2008; 13(2):024019.
PMID: 18465982
PMC: 3970814.
DOI: 10.1117/1.2904658.
Critical evaluation of diagnostic aids for the detection of oral cancer.
Lingen M, Kalmar J, Karrison T, Speight P
Oral Oncol. 2007; 44(1):10-22.
PMID: 17825602
PMC: 2424250.
DOI: 10.1016/j.oraloncology.2007.06.011.
Oral premalignancy: new methods of detection and treatment.
Gillenwater A, Papadimitrakopoulou V, Richards-Kortum R
Curr Oncol Rep. 2006; 8(2):146-54.
PMID: 16507225
PMC: 2773158.
DOI: 10.1007/s11912-006-0050-4.
Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma.
Otake M, Nishiwaki M, Kobayashi Y, Baba S, Kohno E, Kawasaki T
Br J Cancer. 2003; 89(4):730-6.
PMID: 12915887
PMC: 2376916.
DOI: 10.1038/sj.bjc.6601135.